📰 Alvogen News
Alvogen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alvogen. Real-time updates on events, politics, business and more.
June 6, 2023
LOTUS, ALVOGEN, NRX PHARMACEUTICALS COLLABORATE TO DEVELOP AND COMMERCIALISE NRX-101
June 5, 2023
NRx Pharmaceuticals, Lotus Pharmaceuticals, and Alvogen to collaborate on the further development and commercialization of NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD) for global markets
December 22, 2022
Ruling bars ANDA filer Alvogen from entering market until 2032 patent expirySTOUGHTON, Mass., Dec. 22, 2022 -- Collegium Pharmaceutical, Inc. , a leading, diversified specialty pharmaceutical... | December 22, 2022
November 26, 2021
The Consortium jointly, through Aztiq II HoldCo, will acquire a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo
March 8, 2021
Natco Pharma jumped 6.2% to Rs 884.35 after the company received final approval for everolimus tablets in the US market.Natco Pharma announced that its marketing partner, Breckenridge Pharmaceutical Inc. (BPI), has received final approval for its abbreviated new drug application (ANDA) for everolimus tablets (a generic version of Afinitor) from the US Food and Drug Administration (USFDA). BPI plans to launch 2.5 mg, 5 mg and 7.5 mg strengths of the product shortly within the next few weeks. T...